Train and EMPOWER A Community Health Workforce (TEACH)

August 9, 2026 updated by: Katherine Sanchez, Baylor Research Institute

The investigators propose a multi-step approach to improve access to mental health care. The plan focuses on three goals: increasing diversity in the mental health workforce, bringing more expertise into the community, and strengthening the community's ability to address the factors that impact mental health.

To do this, the TEACH study team will work with students from underrepresented groups at a minority-serving institution (MSI). Students will be provided the opportunity to obtain their CHW Certification while receiving course credit for their degree. Students will then be eligible to participate in an internship to utilize their skills. The TEACH study team will help these students with their training, supervision, and ongoing support. These students will then be able to work with their communities to tackle common mental health issues and the social factors that contribute to those problems.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Arlington, Texas, United States, 76019
        • The University of Texas at Arlington
      • Dallas, Texas, United States, 75204
        • Baylor Scott and White Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Must be enrolled as a UTA undergraduate student with unmet internship hours
  • Must be aged 18 and over
  • Must be able to provide informed consent.
  • Must have successful completion of the UTA CHW/EMPOWER course (Phase 2) and/or State of Texas CHW certification (for non-EMPOWER-trained CHWs) at the start of internship

Exclusion Criteria:

  • Under 18 years
  • Not enrolled as an undergraduate student at UTA
  • Unable to provide informed consent
  • Non-successful completion of EMPOWER course and/or State of Texas CHW certification at the start of internship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EMPOWER-trained CHWs
Undergraduate students at the University of Texas at Arlington will engage in a semester-long course for training of students as CHWs with additional EMPOWER training for delivering a brief trans-diagnostic psychosocial intervention. CHW certified students will then engage in an internship at Baylor Scott and White Health.
Students will participate in a special topics course resulting in a CHW certification with the state of Texas. The course will focus on behavioral activation training. Undergraduate Bachelor of Social Work (BSW) students will then be deployed to the Baylor Scott and White Health system as certified CHWs with psychosocial training to provide a sufficient level of care for many, and an entry point to clinical care for those who have needs that are currently unaddressed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Community Health Worker certification plus EMPOWER
Time Frame: Six months after consent/enrollment
Successful completion of the Special Topics course (to include EMPOWER training) which leads to CHW certification.
Six months after consent/enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internship completion
Time Frame: Two semesters after the completion of the CHW course
Successful placement and completion of required undergraduate internship with TEACH partner, Baylor Scott and White Health System
Two semesters after the completion of the CHW course
Behavioral Activation (BA) competencies
Time Frame: Upon completion of the BA training as measured during the internship
Successful demonstration of competencies in BA skills as measured by the World Health Organization EQUIP tool (https://equipcompetency.org/)
Upon completion of the BA training as measured during the internship

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine Sanchez, PhD, LCSW, The University of Texas at Arlington

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 6, 2024

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

February 26, 2025

First Submitted That Met QC Criteria

March 7, 2025

First Posted (Actual)

March 11, 2025

Study Record Updates

Last Update Posted (Actual)

August 11, 2026

Last Update Submitted That Met QC Criteria

August 9, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe